Lumpy skin disease orsakas av ett poxvirus och är närbesläktat med får- och getkoppor. Nötkreatur är det enda tamdjur som kan drabbas.
I Veterinära författningshandboken kan du läsa mer om den lagstiftning som gäller vid epizootisjukdomar.
Lumpy skin disease orsakas av ett poxvirus och är närbesläktat med får- och getkoppor. Nötkreatur är det enda tamdjur som kan drabbas.
I Veterinära författningshandboken kan du läsa mer om den lagstiftning som gäller vid epizootisjukdomar.
https://pubmed.ncbi.nlm.nih.gov/41016799/
Measles virus is the pathogen that causes measles and is highly infectious. Measles virus uses two molecules as viral receptors: signaling lymphocytic activation molecule, expressed on immune cells, and nectin-4, expressed on epithelial cells. Usage of these receptors is strongly associated with the pathogenesis of measles. Although it remains a leading cause of childhood mortality worldwide, measles elimination is being promoted by the availability of a highly effective live attenuated vaccines. Due to the elimination of measles in many countries, the circulating measles genotypes have been reduced to two, B3 and D8, in recent years. Therefore, in addition to genotyping using the conventional 450-nucleotide N gene region, new methods such as wholegenome sequencing and analysis of the M-F non-coding region are being tested for case association and outbreak tracking. Although measles virus is a single serotype, there are genomic differences among genotypes, including variations in B-cell and T-cell epitopes. However, current live attenuated vaccines remain sufficiently effective against all genotypes. On the other hand, the maintenance of protective immunity in vaccinees may become increasingly important, since vaccine-induced immunity tends to wane over time unlike the more durable immunity following natural infection.
https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=11234
Lumpy skin disease virus (LSDV), a member of the capripoxvirus genus of the Poxviridae, is the etiologic agent of an important disease of cattle in Africa. Here we report the genomic sequence of LSDV. The 151-kbp LSDV genome consists of a central coding region bounded by identical 2.4 kbp-inverted terminal repeats and contains 156 putative genes. Comparison of LSDV with chordopoxviruses of other genera reveals 146 conserved genes which encode proteins involved in transcription and mRNA biogenesis, nucleotide metabolism, DNA replication, protein processing, virion structure and assembly, and viral virulence and host range. In the central genomic region, LSDV genes share a high degree of colinearity and amino acid identity (average of 65%) with genes of other known mammalian poxviruses, particularly suipoxvirus, yatapoxvirus, and leporipoxviruses. In the terminal regions, colinearity is disrupted and poxvirus homologues are either absent or share a lower percentage of amino acid identity (average of 43%). Most of these differences involve genes and gene families with likely functions involving viral virulence and host range. Although LSDV resembles leporipoxviruses in gene content and organization, it also contains homologues of interleukin-10 (IL-10), IL-1 binding proteins, G protein-coupled CC chemokine receptor, and epidermal growth factor-like protein which are found in other poxvirus genera. These data show that although LSDV is closely related to other members of the Chordopoxvirinae, it contains a unique complement of genes responsible for viral host range and virulence.
Capripoxviruses (CaPVs) represent one of eight genera within the chordopoxvirus (ChPV) subfamily of the Poxviridae.
These viruses are responsible for some of the most economically significant diseases of domestic ruminants in Africa and Asia (18). CaPV infections are generally host specific and they have specific geographic distributions (10, 14, 15). CaPVs are, however, serologically indistinguishable from each other, able to induce heterologous cross-protection, and able in some instances to experimentally cross-infect (8, 10, 15, 16). Restriction fragment analysis and limited DNA sequence data support a close relationship between CaPVs (5, 25, 26, 33). The molecular basis of CaPV host range restriction and virulence remains to be elucidated.
LSD is a subacute to acute cattle disease in Africa. It is characterized by extensive cutaneous lesions and signs typical of generalized poxvirus diseases (14, 15). Transmission of LSD between cattle is inefficient, and arthropod-vectored transmission may be significant in epizootic outbreaks and in the spread of LSD into nonenzootic regions (4, 10–12, 15, 36, 54).
Attenuated LSDV strains and ShPV have been successfully used as LSD vaccines in enzootic and outbreak areas; however, vaccine failure and restrictions on the use of live virus vaccines create the need for a safe and effective, live attenuated vaccine (4, 13, 15, 53).
Current molecular data on the LSDV genome consists of restriction endonuclease analysis, cross-hybridization studies, and limited transcriptional and DNA sequence analysis (5, 19, 20, 26, 27, 33). Given the economic significance of LSD, its potential for spread into nonenzootic regions, and the interest in developing more effective LSDV-based vaccines and expression vectors, we have sequenced and analyzed the genome of a pathogenic LSDV. These data provide the first view of a CaPV genome, and they define the gene complement that underlies LSDV virulence and host range.
---
LSDV contains 156 ORFs which have been annotated here as putative genes. These genes represent a 95% coding density and encode proteins of 53 to 2,025 amino acids (Fig. 1, Table 1). Similar to other poxviruses, many of the 41 putative early genes are members of gene families and/or putative host range genes, while the 46 genes containing the VV late promoter sequence (TAAATG) at the ATG codon (41) include many of the conserved virion-associated poxviral genes (Table 1).
Otan vain yhden proteiinin rrakenteen, siin on KELCH-proteiinin rakenne selvittettynä, propellitLOCUS VC13_SWPVK 500 aa linear VRL 05-FEB-2025 DEFINITION RecName: Full=Protein C13. ACCESSION P32206 VERSION P32206.1 DBSOURCE UniProtKB: locus VC13_SWPVK, accession P32206; class: standard. created: Oct 1, 1993. sequence updated: Oct 1, 1993. annotation updated: Feb 5, 2025. xrefs: L22013.1, AAC37858.1 xrefs (non-sequence databases): SMR:P32206, Gene3D:1.25.40.420, Gene3D:2.120.10.80, Gene3D:3.30.710.10, InterPro:IPR011705, InterPro:IPR000210, InterPro:IPR015915, InterPro:IPR006652, InterPro:IPR011333, PANTHER:PTHR24412, PANTHER:PTHR24412:SF489, Pfam:PF07707, Pfam:PF00651, Pfam:PF01344, SMART:SM00875, SMART:SM00225, SMART:SM00612, SUPFAM:SSF117281, SUPFAM:SSF54695, PROSITE:PS50097 KEYWORDS Kelch repeat; Repeat. SOURCE Swinepox virus (STRAIN KASZA) ORGANISM Swinepox virus (STRAIN KASZA) Viruses; Varidnaviria; Bamfordvirae; Nucleocytoviricota; Pokkesviricetes; Chitovirales; Poxviridae; Chordopoxvirinae; Suipoxvirus; Suipoxvirus swinepox. REFERENCE 1 (residues 1 to 500) AUTHORS Massung,R.F., Jayarama,V. and Moyer,R.W. TITLE DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue JOURNAL Virology 197 (2), 511-528 (1993) PUBMED 8249275 REMARK NUCLEOTIDE SEQUENCE. COMMENT [SIMILARITY] Belongs to the poxviruses Kelch family. {ECO:0000305}. FEATURES Location/Qualifiers source 1..500 /organism="Swinepox virus (STRAIN KASZA)" /host="Sus scrofa (Pig)" /db_xref="taxon:10277" gene 1..500 /locus_tag="C13L" Protein 1..500 /product="Protein C13" /UniProtKB_evidence="Inferred from homology" Region 1..500 /region_name="Mature chain" /note="Protein C13. /id=PRO_0000119169." Region 17..500 /region_name="PHA03098" /note="kelch-like protein; Provisional" /db_xref="CDD:222983" Region 27..89 /region_name="Domain" /note="BTB. /evidence=ECO:0000255|PROSITE-ProRule:PRU00037." Region 301..348 /region_name="Repetitive region" /note="Kelch 1." Region 338..381 /region_name="KELCH repeat" /note="KELCH repeat [structural motif]" /db_xref="CDD:276965" Region 349..395 /region_name="Repetitive region" /note="Kelch 2." Region 385..427 /region_name="KELCH repeat" /note="KELCH repeat [structural motif]" /db_xref="CDD:276965" Region 397..440 /region_name="Repetitive region" /note="Kelch 3." Region 430..477 /region_name="KELCH repeat" /note="KELCH repeat [structural motif]" /db_xref="CDD:276965" Region 441..490 /region_name="Repetitive region" /note="Kelch 4." ORIGIN 1 mskqetyidy nyierlnavn lnrsydeeiv fimtvggvvk vkkellvsvs nyfklitknq 61 sneitvsfqy esfldiikyi etgivtidld nvenifsisc skaidflkns cidfmskhit 121 dstcvkiyki gfsngcfavy ndaiayirkr ftkietdill slslfdlrii lksgeldvss 181 eddvllfiik wsrhkksnrr ksftlvtevl rynylsiygk ykltkwlarf gknnnvelne 241 nelprisyqh rftnrrytmv tpssfsinml gnvsvknels iinsiaenhn pycgsvlmnd 301 ilyliggink sldpvsdits vdtrsfielh tppllhprkc pgvaifknri yvvggigydg 361 plktveswsp geqqwreevp llqprfnpci igtdndlyvv ggiseddkti eiysyeentw 421 signamnysh fggciayhhg yiymigglsf idnihvftmv ekynphsnkw tvekslpfpr 481 fnsslciied siaiigwiyy //
Tämä virus käyttää KELCH-proteiiniraknnetta edukseen
Clinical signs vary, with younger animals more severely affected.
Keywords: Africa; Kelch-like proteins; Lumpy Skin Disease Virus (LSDV); SNP mutations; ankyrin repeat proteins; genomic analysis; phylogenetic analysis; poxviruses; vaccine efficacy; vector transmission.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01950-6/fulltext?rss=yes
https://www.genecards.org/cgi-bin/carddisp.pl?gene=BST2&keywords=BST2
Bone marrow stromal cells are involved in the growth and development of B-cells. The specific function of the protein encoded by the bone marrow stromal cell antigen 2 is undetermined; however, this protein may play a role in pre-B-cell growth and in rheumatoid arthritis. [provided by RefSeq, Jul 2008]
BST2 (Bone Marrow Stromal Cell Antigen 2) is a Protein Coding gene. Diseases associated with BST2 include Stomatitis and Colorado Tick Fever. Among its related pathways are Infectious disease and SARS-CoV-1-host interactions. Gene Ontology (GO) annotations related to this gene include RNA binding and obsolete signal transducer activity.
IFN-induced antiviral host restriction factor which efficiently blocks the release of diverse mammalian enveloped viruses by directly tethering nascent virions to the membranes of infected cells. Acts as a direct physical tether, holding virions to the cell membrane and linking virions to each other. The tethered virions can be internalized by endocytosis and subsequently degraded or they can remain on the cell surface. In either case, their spread as cell-free virions is restricted (PubMed:18200009, 18342597, 19036818, 19879838, 20019814, 20399176, 20419159, 20940320, 21529378, 22520941, 37922253). Its target viruses belong to diverse families, including retroviridae: human immunodeficiency virus type 1 (HIV-1), human immunodeficiency virus type 2 (HIV-2), simian immunodeficiency viruses (SIVs), equine infectious anemia virus (EIAV), feline immunodeficiency virus (FIV), prototype foamy virus (PFV), Mason-Pfizer monkey virus (MPMV), human T-cell leukemia virus type 1 (HTLV-1), Rous sarcoma virus (RSV) and murine leukemia virus (MLV), flavivirideae: hepatitis C virus (HCV), filoviridae: ebola virus (EBOV) and marburg virus (MARV), arenaviridae: lassa virus (LASV) and machupo virus (MACV), herpesviridae: kaposis sarcoma-associated herpesvirus (KSHV), rhabdoviridae: vesicular stomatitis virus (VSV), orthomyxoviridae: influenza A virus, paramyxoviridae: nipah virus, and coronaviridae: SARS-CoV (PubMed:18200009, 18342597, 19179289, 19879838, 20399176, 20419159, 20686043, 20943977, 21529378, 21621240, 22520941, 26378163, 31199522). Can inhibit cell surface proteolytic activity of MMP14 causing decreased activation of MMP15 which results in inhibition of cell growth and migration (PubMed:22065321). Can stimulate signaling by LILRA4/ILT7 and consequently provide negative feedback to the production of IFN by plasmacytoid dendritic cells in response to viral infection (PubMed:19564354, 26172439). Plays a role in the organization of the subapical actin cytoskeleton in polarized epithelial cells. Isoform 1 and isoform 2 are both effective viral restriction factors but have differing antiviral and signaling activities (PubMed:23028328, 26172439). Isoform 2 is resistant to HIV-1 Vpu-mediated degradation and restricts HIV-1 viral budding in the presence of Vpu (PubMed:23028328, 26172439). Isoform 1 acts as an activator of NF-kappa-B and this activity is inhibited by isoform 2 (PubMed:23028328). ( BST2_HUMAN,Q10589 )
Lisätieto 6.10.-2025: EBOV , proteiini GP .
https://ictv.global/report/chapter/filoviridae/filoviridae/orthoebolavirus
GeneCards tieto: Virion adsorption to orthoebolavirus susceptible cells via cellular attachment factors; determines orthoebolavirus cell and tissue tropism; induction of virus cell membrane fusion subsequent to endolysosomal binding to NPC1; inhibits innate immune response by interfering with BST2. GP1,2Δ triggers immune activation and increased vascular permeability
PubMed haku: EBOV interaction with BST2? 5 vastausta: